You are viewing the site in preview mode
Skip to main content
|
Characteristics
|
Total
|
No stroke
|
Stroke
|
p value
|
|---|
| |
N = 265
|
N = 254
|
N = 11
| |
|
Age, years
|
85.9 ± 6.5
|
85.8 ± 6.6
|
87.1 ± 4.5
|
0.398
|
|
Length of stay in acute care, days
|
12.6 ± 7.7
|
12.7 ± 7.7
|
11.9 ± 7.8
|
0.645
|
|
Male sex
|
114 (43.0%)
|
109 (42.9%)
|
5 (45.5%)
|
> 0.999
|
|
Help in ADL/IADL
|
127 (47.9%)
|
121 (47.6%)
|
6 (54.5%)
|
0.762
|
|
Mortality
|
85 (32.1%)
|
82 (32.3%)
|
3 (27.3%)
|
> 0.999
|
|
Number of medications
|
7.4 ± 4.1
|
7.4 ± 4.1
|
6.4 ± 3.0
|
0.286
|
|
Heart failure
|
93 (36.5%)
|
90 (36.9%)
|
3 (27.3%)
|
0.750
|
|
COPD
|
30 (11.4%)
|
27 (10.7%)
|
3 (27.3%)
|
0.117
|
|
Active smoking
|
15 (5.7%)
|
12 (4.8%)
|
3 (27.3%)
|
0.019
|
|
Kidney disease
|
74 (28.2%)
|
70 (27.9%)
|
4 (36.4%)
|
0.510
|
|
Diabetes under treatment
|
63 (24.0%)
|
60 (23.9%)
|
3 (27.3%)
|
0.728
|
|
Cognitive impairment
|
134 (51.0%)
|
127 (50.4%)
|
7 (63.6%)
|
0.540
|
|
Active neoplasia
|
23 (8.8%)
|
22 (8.8%)
|
1 (9.1%)
|
> 0.999
|
|
History of coronary disease
|
36 (13.6%)
|
35 (13.8%)
|
1 (9.1%)
|
> 0.999
|
|
History of stroke
|
40 (15.2%)
|
35 (13.8%)
|
5 (45.5%)
|
0.014
|
|
Atrial fibrillation
|
61 (23.1%)
|
58 (22.9%)
|
3 (27.3%)
|
0.719
|
|
Hypertension
|
187 (70.8%)
|
179 (70.8%)
|
8 (72.7%)
|
> 0.999
|
|
Dyslipidemia
|
91 (34.5%)
|
84 (33.2%)
|
7 (63.6%)
|
0.051
|
|
PE or DVT
|
6 (2.26%)
|
6 (2.36%)
|
0
|
> 0.999
|
|
BMI, kg × m−2
|
24.8 ± 6.4
|
24.9 ± 6.4
|
20.7 ± 3.5
|
0.002
|
|
Asymptomatic
|
22 (8.5%)
|
19 (7.7%)
|
3 (27.3%)
|
0.056
|
|
Cough
|
160 (61.5%)
|
155 (62.2%)
|
5 (45.5%)
|
0.344
|
|
Dyspnea
|
99 (38.1%)
|
95 (38.2%)
|
4 (36.4%)
|
> 0.999
|
|
Tiredness
|
126 (48.5%)
|
125 (50.2%)
|
1 (9.1%)
|
0.010
|
|
Falls
|
30 (11.5%)
|
28 (11.2%)
|
2 (18.2%)
|
0.369
|
|
Delirium
|
53 (20.4%)
|
49 (19.7%)
|
4 (36.4%)
|
0.242
|
|
FIM (18–126)
|
71.8 ± 29.4
|
72.2 ± 29.7
|
62.1 ± 20.7
|
0.222
|
|
CIRS-G (0–56)
|
19.1 ± 6.2
|
19.0 ± 6.3
|
20.3 ± 2.3
|
0.170
|
|
CFS ≥5
|
190 (80.9%)
|
182 (80.5%)
|
8 (88.9%)
|
> 0.999
|
|
PSI (0–395)
|
126.1 ± 53.9
|
125.9 ± 54.7
|
130.7 ± 32.3
|
0.650
|
|
CURB-65
| | | |
0.960
|
|
1–2
|
168 (63.6%)
|
161 (63.6%)
|
7 (63.6%)
| |
|
3
|
86 (32.6%)
|
82 (32.4%)
|
4 (36.4%)
| |
|
4–5
|
10 (3.8%)
|
10 (4.0%)
|
0 (0.0%)
| |
|
FiO2, %
|
26.4 ± 9.6
|
26.5 ± 9.6
|
24.2 ± 7.5
|
0.394
|
|
Lymphocytes, G/l
|
1.2 ± 1.3
|
1.2 ± 1.3
|
1.0 ± 0.5
|
0.361
|
|
Pro-brain natriuretic peptide, pg/ml
|
5904.0 ± 10,525.5
|
5129.4 ± 8216.0
|
25,657.8 ± 32,622.7
|
0.297
|
|
C-reactive protein, mg/l
|
67.8 ± 72.0
|
66.4 ± 71.1
|
98.1 ± 89.1
|
0.270
|
- Abbreviations: ADL activities of daily living, IADL instrumental activities of daily living, COPD chronic obstructive pulmonary disease, PE pulmonary embolism, DVT deep vein thrombosis, BMI body mass index, FIM Functional Independence Measure, CIRS-G Cumulative Illness Rating Scale-Geriatric, CFS Clinical Frailty Score, PSI pneumonia severity index, FiO2 Fraction of inspired oxygen